Barclays
MMSI icon

Barclays’s Merit Medical Systems MMSI Stock Holding History

Barclays’s Portfolio MMSI Stock Details MMSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18,000
Closed -$562K – 6344
2019
Q4 		$562K Buy
+18,000
New +$515K ﹤0.01% 4197
2019
Q3 		– Sell
-161,400
Closed -$9.61M – 6969
2019
Q2 		$9.61M Buy
161,400
+108,700
+206% +$6.23M 0.01% 1380
2019
Q1 		$3.26M Buy
+52,700
New +$2.99M ﹤0.01% 2056

Other funds holding MMSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Barclays's MMSI Position: Q1 2026 in Review

Barclays reduced its Merit Medical Systems (MMSI) stake by 35% in Q1 2026, selling an estimated $2.58M and leaving 61,260 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Barclays first reported a position in MMSI in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.7M in Q1 2025. 399 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.

  • Barclays held 61,260 shares of Merit Medical Systems worth $4.22M as of Q1 2026.
  • Barclays sold 32,990 Merit Medical Systems shares in Q1 2026, an estimated $2.58M.
  • Merit Medical Systems made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1923 holding.
  • Barclays first reported a position in Merit Medical Systems in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Merit Medical Systems position peaked at $13.7M in Q1 2025.
  • 399 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.